Fri, February 17, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Ygal Arounian Maintained (TTD) at Strong Buy with Increased Target to $76 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Kenneth Lee Maintained (TWO) at Hold with Increased Target to $17 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Ed Arce Reiterated (TVTX) at Strong Buy and Held Target at $36 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Alex Zukin Maintained (TYL) at Buy with Increased Target to $365 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joe Goodwin Maintained (TYL) at Buy and Held Target at $415 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Rob Oliver Maintained (TYL) at Buy and Held Target at $440 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joshua Reilly Maintained (TYL) at Strong Buy and Held Target at $475 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Clarke Jeffries Maintained (TYL) at Buy with Decreased Target to $450 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Christopher Danely Maintained (TXRH) at Hold with Decreased Target to $101 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Lauren Silberman Maintained (TXRH) at Buy with Decreased Target to $115 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
David Tarantino Maintained (TXRH) at Hold with Increased Target to $108 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Nick Setyan Maintained (TXRH) at Buy with Increased Target to $114 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Chris O"Cull Downgraded (TXRH) to Hold and Decreased Target to $105 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joshua Long Reiterated (TXRH) at Hold and Held Target at $86 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Jeff Van Sinderen Downgraded (UEIC) to Hold and Decreased Target to $22 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Steve Frankel Downgraded (UEIC) to Hold and Held Target at $20 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Eric Sheridan Maintained (UPWK) at Strong Buy with Decreased Target to $21 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Jeffrey Zekauskas Maintained (TROX) at Buy and Held Target at $18 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Dan Dolev Maintained (TOST) at Strong Buy with Decreased Target to $23 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Timothy Chiodo Maintained (TOST) at Hold with Increased Target to $23 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Andrew Bauch Downgraded (TOST) to Hold and Decreased Target to $23 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Brent Bracelin Maintained (TOST) at Buy with Increased Target to $23 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Mayank Tandon Maintained (TOST) at Strong Buy with Decreased Target to $30 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Josh Beck Maintained (TOST) at Buy with Decreased Target to $26 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Stephen Baxter Maintained (THC) at Buy with Increased Target to $68 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Ann Hynes Maintained (THC) at Strong Buy with Increased Target to $78 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Michael Swartz Maintained (THO) at Hold with Increased Target to $80 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Jerry Revich Maintained (ALSN) at Strong Sell with Increased Target to $37 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Mehdi Hosseini Maintained (AMAT) at Hold and Held Target at $125 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Harlan Sur Maintained (AMAT) at Buy with Increased Target to $140 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Atif Malik Maintained (AMAT) at Strong Buy with Increased Target to $136 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joseph Quatrochi Maintained (AMAT) at Buy with Increased Target to $135 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joseph Moore Maintained (AMAT) at Hold with Increased Target to $125 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Craig Ellis Maintained (AMAT) at Strong Buy with Increased Target to $150 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Vijay Rakesh Maintained (AMAT) at Strong Buy with Increased Target to $136 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Toshiya Hari Maintained (AMAT) at Strong Buy with Increased Target to $120 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Quinn Bolton Maintained (AMAT) at Strong Buy with Increased Target to $135 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Michael Lasser Maintained (TGT) at Strong Buy with Increased Target to $202 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Greg Melich Reiterated (TGT) at Hold and Held Target at $155 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Filippo Falorni Initiated (TAP) at Hold and Held Target at $55 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Yaron Kinar Maintained (AIG) at Strong Buy with Increased Target to $75 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Colin Rusch Maintained (ALB) at Buy with Increased Target to $498 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Christopher Parkinson Maintained (ALB) at Hold with Increased Target to $328 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Joel Jackson Maintained (ALB) at Buy with Increased Target to $325 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Moshe Orenbuch Reiterated (AL) at Buy and Held Target at $55 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Douglas Tsao Reiterated (ALKS) at Hold and Held Target at $32 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Filippo Falorni Initiated (STZ) at Strong Buy and Held Target at $265 on, Feb 17th, 2023
[ Fri, Feb 17th 2023 ]: WOPRAI
Liam Burke Maintained (STNG) at Strong Buy with Increased Target to $80 on, Feb 17th, 2023

Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $26 on, Feb 17th, 2023

Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $26 on, Feb 17th, 2023.

Joseph has made no other calls on CARA in the last 4 months.



There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph

  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, February 14th, 2023